IsoPlexis Corp
NASDAQ:ISO
IsoPlexis Corp
NASDAQ:ISO
Price:
0.7616 USD
Updated:
May 1, 2024
IsoPlexis Corp
Operating Income
|
IsoPlexis Corp
Operating Income Peer Comparison
Comparables:
TMO
DHR
MTD
A
IQV
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
IsoPlexis Corp
NASDAQ:ISO
|
Operating Income
-$97m
|
CAGR 3-Years
-75%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Operating Income
$7.3B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
14%
|
CAGR 10-Years
15%
|
|
|
Danaher Corp
NYSE:DHR
|
Operating Income
$9.5B
|
CAGR 3-Years
20%
|
CAGR 5-Years
26%
|
CAGR 10-Years
12%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Operating Income
$1.1B
|
CAGR 3-Years
11%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Operating Income
$1.3B
|
CAGR 3-Years
11%
|
CAGR 5-Years
6%
|
CAGR 10-Years
16%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Operating Income
$2.1B
|
CAGR 3-Years
38%
|
CAGR 5-Years
21%
|
CAGR 10-Years
16%
|
See Also
What is IsoPlexis Corp's Operating Income?
Operating Income
-97m
USD
-97m
USD
Based on the financial report for Dec 31, 2022, IsoPlexis Corp's Operating Income amounts to -97m USD.
What is IsoPlexis Corp's Operating Income growth rate?
Operating Income CAGR 3Y
-75%
-75%
Over the last year, the Operating Income growth was -27%. The average annual Operating Income growth rates for IsoPlexis Corp have been -75% over the past three years .
You don't have any saved screeners yet
